Stock Information
Syndax Pharmaceuticals Inc (SNDX)
Ticker Symbol: SNDX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,886.92 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.3003
Revenue (TTM): $1.99 M
Dividend Yield: N/A%
ROE: -206.62%
Latest News
-
Syndax Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation
Tue, Mar 3, 2026 6:12 PM
-
Citigroup Maintains Buy on Syndax Pharmaceuticals, Raises Price Target to $57
Mon, Mar 2, 2026 3:19 PM
-
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) Reports Mixed Q4 2025 Results with Revenue Beat and Wider-Than-Expected Loss
Thu, Feb 26, 2026 11:30 PM
-
Syndax Pharmaceuticals, Inc. (SNDX) Q4 2025 Earnings Call Transcript
Thu, Feb 26, 2026 10:47 PM
-
Insights into Syndax Pharmaceuticals Q4 Earnings
Thu, Feb 26, 2026 5:10 PM
-
Syndax Pharmaceuticals Q4 EPS $(0.78) Misses $(0.58) Estimate, Sales $68.728M Beat $63.968M Estimate.
Thu, Feb 26, 2026 5:09 PM
-
Earnings Scheduled For February 26, 2026
Thu, Feb 26, 2026 7:11 AM
Key Financials
Financial data not available
